The global market for Clinical Trial Site Management Outsourcing (SMO) was estimated to be worth US$ 5689 million in 2023 and is forecast to a readjusted size of US$ 8957.9 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030

Clinical Trial Site Management Outsourcing (SMO) - Market

A Clinical Trial Site Management Outsourcing (SMO) is an organization that provides clinical trial related services to a contract research organization (CRO), a pharmaceutical company, a biotechnology company, a medical device company or a clinical site.

The number of clinical trials has increased dramatically in recent years. The total number of clinical trials in 2020 was 325,773, and as of April 2022, the number of clinical trials was 410,903, according to Clinical Trials.gov. The growth in clinical trial activities has brought profits to the market for clinical site management organizations (SMOs). The complexity of clinical trials increases the need for CROs. The large number of CROs offering organizational solutions for clinical trial site management further contributes to the market growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Clinical Trial Site Management Outsourcing (SMO), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trial Site Management Outsourcing (SMO) by region & country, by Type, and by Application.

The Clinical Trial Site Management Outsourcing (SMO) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Site Management Outsourcing (SMO).

Market Segmentation

Scope of Clinical Trial Site Management Outsourcing (SMO) - Market Report

Report Metric	Details
Report Name	Clinical Trial Site Management Outsourcing (SMO) - Market
Forecasted market size in 2030	US$ 8957.9 million
CAGR	7.0%
Forecasted years	2024 - 2030
Segment by Type:	SMOs Own and Operate Themself Broker
Segment by Application	Oncology Endocrinology Respiration Neurology Cardiology Immunology Infection Ophthalmology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novotech, FOMAT Medical Research, MEDEX, ClinChoice, PAS Research, Excellence SMO, Irom Group, ACE Research, Biopharma Informatic, Panthera, SGS, CMIC Group, EP-SOGO, ACTG-CRO
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Clinical Trial Site Management Outsourcing (SMO) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Clinical Trial Site Management Outsourcing (SMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Clinical Trial Site Management Outsourcing (SMO) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Clinical Trial Site Management Outsourcing (SMO) - Market size in 2030?

Ans: The Clinical Trial Site Management Outsourcing (SMO) - Market size in 2030 will be US$ 8957.9 million.

Who are the main players in the Clinical Trial Site Management Outsourcing (SMO) - Market report?

Ans: The main players in the Clinical Trial Site Management Outsourcing (SMO) - Market are Novotech, FOMAT Medical Research, MEDEX, ClinChoice, PAS Research, Excellence SMO, Irom Group, ACE Research, Biopharma Informatic, Panthera, SGS, CMIC Group, EP-SOGO, ACTG-CRO

What are the Application segmentation covered in the Clinical Trial Site Management Outsourcing (SMO) - Market report?

Ans: The Applications covered in the Clinical Trial Site Management Outsourcing (SMO) - Market report are Oncology, Endocrinology, Respiration, Neurology, Cardiology, Immunology, Infection, Ophthalmology, Others

What are the Type segmentation covered in the Clinical Trial Site Management Outsourcing (SMO) - Market report?

Ans: The Types covered in the Clinical Trial Site Management Outsourcing (SMO) - Market report are SMOs Own and Operate Themself, Broker

1 Market Overview

1.1 Clinical Trial Site Management Outsourcing (SMO) Product Introduction

1.2 Global Clinical Trial Site Management Outsourcing (SMO) Market Size Forecast

1.3 Clinical Trial Site Management Outsourcing (SMO) Market Trends & Drivers

1.3.1 Clinical Trial Site Management Outsourcing (SMO) Industry Trends

1.3.2 Clinical Trial Site Management Outsourcing (SMO) Market Drivers & Opportunity

1.3.3 Clinical Trial Site Management Outsourcing (SMO) Market Challenges

1.3.4 Clinical Trial Site Management Outsourcing (SMO) Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Clinical Trial Site Management Outsourcing (SMO) Players Revenue Ranking (2023)

2.2 Global Clinical Trial Site Management Outsourcing (SMO) Revenue by Company (2019-2024)

2.3 Key Companies Clinical Trial Site Management Outsourcing (SMO) Manufacturing Base Distribution and Headquarters

2.4 Key Companies Clinical Trial Site Management Outsourcing (SMO) Product Offered

2.5 Key Companies Time to Begin Mass Production of Clinical Trial Site Management Outsourcing (SMO)

2.6 Clinical Trial Site Management Outsourcing (SMO) Market Competitive Analysis

2.6.1 Clinical Trial Site Management Outsourcing (SMO) Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Clinical Trial Site Management Outsourcing (SMO) Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Site Management Outsourcing (SMO) as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 SMOs Own and Operate Themself

3.1.2 Broker

3.2 Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type

3.2.1 Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Clinical Trial Site Management Outsourcing (SMO) Sales Value, by Type (2019-2030)

3.2.3 Global Clinical Trial Site Management Outsourcing (SMO) Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Oncology

4.1.2 Endocrinology

4.1.3 Respiration

4.1.4 Neurology

4.1.5 Cardiology

4.1.6 Immunology

4.1.7 Infection

4.1.8 Ophthalmology

4.1.9 Others

4.2 Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application

4.2.1 Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Clinical Trial Site Management Outsourcing (SMO) Sales Value, by Application (2019-2030)

4.2.3 Global Clinical Trial Site Management Outsourcing (SMO) Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Region

5.1.1 Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Region (2019-2024)

5.1.3 Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Region (2025-2030)

5.1.4 Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Clinical Trial Site Management Outsourcing (SMO) Sales Value, 2019-2030

5.2.2 North America Clinical Trial Site Management Outsourcing (SMO) Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Clinical Trial Site Management Outsourcing (SMO) Sales Value, 2019-2030

5.3.2 Europe Clinical Trial Site Management Outsourcing (SMO) Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Clinical Trial Site Management Outsourcing (SMO) Sales Value, 2019-2030

5.4.2 Asia Pacific Clinical Trial Site Management Outsourcing (SMO) Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Clinical Trial Site Management Outsourcing (SMO) Sales Value, 2019-2030

5.5.2 South America Clinical Trial Site Management Outsourcing (SMO) Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Clinical Trial Site Management Outsourcing (SMO) Sales Value, 2019-2030

5.6.2 Middle East & Africa Clinical Trial Site Management Outsourcing (SMO) Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Clinical Trial Site Management Outsourcing (SMO) Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Clinical Trial Site Management Outsourcing (SMO) Sales Value

6.3 United States

6.3.1 United States Clinical Trial Site Management Outsourcing (SMO) Sales Value, 2019-2030

6.3.2 United States Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Clinical Trial Site Management Outsourcing (SMO) Sales Value, 2019-2030

6.4.2 Europe Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Clinical Trial Site Management Outsourcing (SMO) Sales Value, 2019-2030

6.5.2 China Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

6.5.3 China Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Clinical Trial Site Management Outsourcing (SMO) Sales Value, 2019-2030

6.6.2 Japan Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Clinical Trial Site Management Outsourcing (SMO) Sales Value, 2019-2030

6.7.2 South Korea Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Clinical Trial Site Management Outsourcing (SMO) Sales Value, 2019-2030

6.8.2 Southeast Asia Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Clinical Trial Site Management Outsourcing (SMO) Sales Value, 2019-2030

6.9.2 India Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

6.9.3 India Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Novotech

7.1.1 Novotech Profile

7.1.2 Novotech Main Business

7.1.3 Novotech Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.1.4 Novotech Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.1.5 Novotech Recent Developments

7.2 FOMAT Medical Research

7.2.1 FOMAT Medical Research Profile

7.2.2 FOMAT Medical Research Main Business

7.2.3 FOMAT Medical Research Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.2.4 FOMAT Medical Research Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.2.5 FOMAT Medical Research Recent Developments

7.3 MEDEX

7.3.1 MEDEX Profile

7.3.2 MEDEX Main Business

7.3.3 MEDEX Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.3.4 MEDEX Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.3.5 ClinChoice Recent Developments

7.4 ClinChoice

7.4.1 ClinChoice Profile

7.4.2 ClinChoice Main Business

7.4.3 ClinChoice Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.4.4 ClinChoice Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.4.5 ClinChoice Recent Developments

7.5 PAS Research

7.5.1 PAS Research Profile

7.5.2 PAS Research Main Business

7.5.3 PAS Research Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.5.4 PAS Research Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.5.5 PAS Research Recent Developments

7.6 Excellence SMO

7.6.1 Excellence SMO Profile

7.6.2 Excellence SMO Main Business

7.6.3 Excellence SMO Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.6.4 Excellence SMO Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.6.5 Excellence SMO Recent Developments

7.7 Irom Group

7.7.1 Irom Group Profile

7.7.2 Irom Group Main Business

7.7.3 Irom Group Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.7.4 Irom Group Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.7.5 Irom Group Recent Developments

7.8 ACE Research

7.8.1 ACE Research Profile

7.8.2 ACE Research Main Business

7.8.3 ACE Research Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.8.4 ACE Research Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.8.5 ACE Research Recent Developments

7.9 Biopharma Informatic

7.9.1 Biopharma Informatic Profile

7.9.2 Biopharma Informatic Main Business

7.9.3 Biopharma Informatic Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.9.4 Biopharma Informatic Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.9.5 Biopharma Informatic Recent Developments

7.10 Panthera

7.10.1 Panthera Profile

7.10.2 Panthera Main Business

7.10.3 Panthera Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.10.4 Panthera Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.10.5 Panthera Recent Developments

7.11 SGS

7.11.1 SGS Profile

7.11.2 SGS Main Business

7.11.3 SGS Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.11.4 SGS Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.11.5 SGS Recent Developments

7.12 CMIC Group

7.12.1 CMIC Group Profile

7.12.2 CMIC Group Main Business

7.12.3 CMIC Group Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.12.4 CMIC Group Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.12.5 CMIC Group Recent Developments

7.13 EP-SOGO

7.13.1 EP-SOGO Profile

7.13.2 EP-SOGO Main Business

7.13.3 EP-SOGO Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.13.4 EP-SOGO Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.13.5 EP-SOGO Recent Developments

7.14 ACTG-CRO

7.14.1 ACTG-CRO Profile

7.14.2 ACTG-CRO Main Business

7.14.3 ACTG-CRO Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

7.14.4 ACTG-CRO Clinical Trial Site Management Outsourcing (SMO) Revenue (US$ Million) & (2019-2024)

7.14.5 ACTG-CRO Recent Developments

8 Industry Chain Analysis

8.1 Clinical Trial Site Management Outsourcing (SMO) Industrial Chain

8.2 Clinical Trial Site Management Outsourcing (SMO) Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Clinical Trial Site Management Outsourcing (SMO) Sales Model

8.5.2 Sales Channel

8.5.3 Clinical Trial Site Management Outsourcing (SMO) Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Novotech

FOMAT Medical Research

List of Tables

Table 1. Clinical Trial Site Management Outsourcing (SMO) Market Trends

Table 2. Clinical Trial Site Management Outsourcing (SMO) Market Drivers & Opportunity

Table 3. Clinical Trial Site Management Outsourcing (SMO) Market Challenges

Table 4. Clinical Trial Site Management Outsourcing (SMO) Market Restraints

Table 5. Global Clinical Trial Site Management Outsourcing (SMO) Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Clinical Trial Site Management Outsourcing (SMO) Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Clinical Trial Site Management Outsourcing (SMO) Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Clinical Trial Site Management Outsourcing (SMO) Product Type

Table 9. Key Companies Time to Begin Mass Production of Clinical Trial Site Management Outsourcing (SMO)

Table 10. Global Clinical Trial Site Management Outsourcing (SMO) Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Site Management Outsourcing (SMO) as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Clinical Trial Site Management Outsourcing (SMO) Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Clinical Trial Site Management Outsourcing (SMO) Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Clinical Trial Site Management Outsourcing (SMO) Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Clinical Trial Site Management Outsourcing (SMO) Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Region (2019-2024) & (%)

Table 27. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Clinical Trial Site Management Outsourcing (SMO) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Clinical Trial Site Management Outsourcing (SMO) Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Clinical Trial Site Management Outsourcing (SMO) Sales Value, (2025-2030) & (US$ Million)

Table 31. Novotech Basic Information List

Table 32. Novotech Description and Business Overview

Table 33. Novotech Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 34. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of Novotech (2019-2024)

Table 35. Novotech Recent Developments

Table 36. FOMAT Medical Research Basic Information List

Table 37. FOMAT Medical Research Description and Business Overview

Table 38. FOMAT Medical Research Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 39. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of FOMAT Medical Research (2019-2024)

Table 40. FOMAT Medical Research Recent Developments

Table 41. MEDEX Basic Information List

Table 42. MEDEX Description and Business Overview

Table 43. MEDEX Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 44. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of MEDEX (2019-2024)

Table 45. MEDEX Recent Developments

Table 46. ClinChoice Basic Information List

Table 47. ClinChoice Description and Business Overview

Table 48. ClinChoice Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 49. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of ClinChoice (2019-2024)

Table 50. ClinChoice Recent Developments

Table 51. PAS Research Basic Information List

Table 52. PAS Research Description and Business Overview

Table 53. PAS Research Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 54. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of PAS Research (2019-2024)

Table 55. PAS Research Recent Developments

Table 56. Excellence SMO Basic Information List

Table 57. Excellence SMO Description and Business Overview

Table 58. Excellence SMO Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 59. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of Excellence SMO (2019-2024)

Table 60. Excellence SMO Recent Developments

Table 61. Irom Group Basic Information List

Table 62. Irom Group Description and Business Overview

Table 63. Irom Group Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 64. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of Irom Group (2019-2024)

Table 65. Irom Group Recent Developments

Table 66. ACE Research Basic Information List

Table 67. ACE Research Description and Business Overview

Table 68. ACE Research Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 69. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of ACE Research (2019-2024)

Table 70. ACE Research Recent Developments

Table 71. Biopharma Informatic Basic Information List

Table 72. Biopharma Informatic Description and Business Overview

Table 73. Biopharma Informatic Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 74. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of Biopharma Informatic (2019-2024)

Table 75. Biopharma Informatic Recent Developments

Table 76. Panthera Basic Information List

Table 77. Panthera Description and Business Overview

Table 78. Panthera Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 79. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of Panthera (2019-2024)

Table 80. Panthera Recent Developments

Table 81. SGS Basic Information List

Table 82. SGS Description and Business Overview

Table 83. SGS Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 84. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of SGS (2019-2024)

Table 85. SGS Recent Developments

Table 86. CMIC Group Basic Information List

Table 87. CMIC Group Description and Business Overview

Table 88. CMIC Group Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 89. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of CMIC Group (2019-2024)

Table 90. CMIC Group Recent Developments

Table 91. EP-SOGO Basic Information List

Table 92. EP-SOGO Description and Business Overview

Table 93. EP-SOGO Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 94. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of EP-SOGO (2019-2024)

Table 95. EP-SOGO Recent Developments

Table 96. ACTG-CRO Basic Information List

Table 97. ACTG-CRO Description and Business Overview

Table 98. ACTG-CRO Clinical Trial Site Management Outsourcing (SMO) Products, Services and Solutions

Table 99. Revenue (US$ Million) in Clinical Trial Site Management Outsourcing (SMO) Business of ACTG-CRO (2019-2024)

Table 100. ACTG-CRO Recent Developments

Table 101. Key Raw Materials Lists

Table 102. Raw Materials Key Suppliers Lists

Table 103. Clinical Trial Site Management Outsourcing (SMO) Downstream Customers

Table 104. Clinical Trial Site Management Outsourcing (SMO) Distributors List

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

Table 108. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Clinical Trial Site Management Outsourcing (SMO) Product Picture

Figure 2. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value (2019-2030) & (US$ Million)

Figure 4. Clinical Trial Site Management Outsourcing (SMO) Report Years Considered

Figure 5. Global Clinical Trial Site Management Outsourcing (SMO) Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Clinical Trial Site Management Outsourcing (SMO) Revenue in 2023

Figure 7. Clinical Trial Site Management Outsourcing (SMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. SMOs Own and Operate Themself Picture

Figure 9. Broker Picture

Figure 10. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Oncology

Figure 13. Product Picture of Endocrinology

Figure 14. Product Picture of Respiration

Figure 15. Product Picture of Neurology

Figure 16. Product Picture of Cardiology

Figure 17. Product Picture of Immunology

Figure 18. Product Picture of Infection

Figure 19. Product Picture of Ophthalmology

Figure 20. Product Picture of Others

Figure 21. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Clinical Trial Site Management Outsourcing (SMO) Sales Value Market Share by Application, 2023 & 2030

Figure 23. North America Clinical Trial Site Management Outsourcing (SMO) Sales Value (2019-2030) & (US$ Million)

Figure 24. North America Clinical Trial Site Management Outsourcing (SMO) Sales Value by Country (%), 2023 VS 2030

Figure 25. Europe Clinical Trial Site Management Outsourcing (SMO) Sales Value (2019-2030) & (US$ Million)

Figure 26. Europe Clinical Trial Site Management Outsourcing (SMO) Sales Value by Country (%), 2023 VS 2030

Figure 27. Asia Pacific Clinical Trial Site Management Outsourcing (SMO) Sales Value (2019-2030) & (US$ Million)

Figure 28. Asia Pacific Clinical Trial Site Management Outsourcing (SMO) Sales Value by Country (%), 2023 VS 2030

Figure 29. South America Clinical Trial Site Management Outsourcing (SMO) Sales Value (2019-2030) & (US$ Million)

Figure 30. South America Clinical Trial Site Management Outsourcing (SMO) Sales Value by Country (%), 2023 VS 2030

Figure 31. Middle East & Africa Clinical Trial Site Management Outsourcing (SMO) Sales Value (2019-2030) & (US$ Million)

Figure 32. Middle East & Africa Clinical Trial Site Management Outsourcing (SMO) Sales Value by Country (%), 2023 VS 2030

Figure 33. Key Countries/Regions Clinical Trial Site Management Outsourcing (SMO) Sales Value (%), (2019-2030)

Figure 34. United States Clinical Trial Site Management Outsourcing (SMO) Sales Value, (2019-2030) & (US$ Million)

Figure 35. United States Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

Figure 36. United States Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application (%), 2023 VS 2030

Figure 37. Europe Clinical Trial Site Management Outsourcing (SMO) Sales Value, (2019-2030) & (US$ Million)

Figure 38. Europe Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

Figure 39. Europe Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application (%), 2023 VS 2030

Figure 40. China Clinical Trial Site Management Outsourcing (SMO) Sales Value, (2019-2030) & (US$ Million)

Figure 41. China Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

Figure 42. China Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application (%), 2023 VS 2030

Figure 43. Japan Clinical Trial Site Management Outsourcing (SMO) Sales Value, (2019-2030) & (US$ Million)

Figure 44. Japan Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

Figure 45. Japan Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application (%), 2023 VS 2030

Figure 46. South Korea Clinical Trial Site Management Outsourcing (SMO) Sales Value, (2019-2030) & (US$ Million)

Figure 47. South Korea Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

Figure 48. South Korea Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application (%), 2023 VS 2030

Figure 49. Southeast Asia Clinical Trial Site Management Outsourcing (SMO) Sales Value, (2019-2030) & (US$ Million)

Figure 50. Southeast Asia Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

Figure 51. Southeast Asia Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application (%), 2023 VS 2030

Figure 52. India Clinical Trial Site Management Outsourcing (SMO) Sales Value, (2019-2030) & (US$ Million)

Figure 53. India Clinical Trial Site Management Outsourcing (SMO) Sales Value by Type (%), 2023 VS 2030

Figure 54. India Clinical Trial Site Management Outsourcing (SMO) Sales Value by Application (%), 2023 VS 2030

Figure 55. Clinical Trial Site Management Outsourcing (SMO) Industrial Chain

Figure 56. Clinical Trial Site Management Outsourcing (SMO) Manufacturing Cost Structure

Figure 57. Channels of Distribution (Direct Sales, and Distribution)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions